Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I don't hold for a specific PT. waiting for next catalyst hopefully will be good like the previous.
What is your target price for this stock? Thanks
OXGN catalysts any time.this is a $10 stock if compare it to market potential IMO.
Nice summary. I enjoyed the HOD finish today, hopefully the trend continues tomorrow...
OXGN
OXGN All in one DD: P2 Study of CA4P in Recurrent Ovarian Cancer already Met Primary Endpoint of Improvement.
http://www.benzinga.com/news/16/05/8022493/oxigene-offers-results-from-phase-2-study-of-ca4p-in-recurrent-ovarian-cancer-stu?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+benzinga+%28Benzinga+News+Feed%29
At $10 cap will be around $200m.still reasonable relating market potential,imo. The FDA already granted a Fast Track status to CA4P. Very solid balance sheet,trading way under Net Assets.
OXGN to hit two birds with one stone,awesome: https://biz.yahoo.com/e/160602/oxgn8-k.html. (shareholders wouldn't have voted to no R/S if weren't pretty sure it wouldn't be necessary imo,Catalyst this month).
June 2016 Catalysts:this https://clinicaltrials.gov/ct2/show/NCT02132468
Assets/debt ratio=12 very solid(even rare),Net Assets(total assets minus total liabilities)= $22m. currently trading under $17m cap.
Many upcoming Catalysts: http://www.oxigene.com/product-
development
Latest Presentation: http://files.shareholder.com/downloads/OXGN/2196652144x0x869782/012F16F4-3081-4294-840D-9CBE0C2221D2/OXiGENE_Corporate_Roadshow_Long_Deck_-_Jan_2016_v2.pdf
They just recieved 180 days to remain over $1. with great former data and upcoming catalysts combined with a very solid balance sheet it won't take too long IMO.
Agree. I'm surprised it isn't trading higher than it is. I figured the vote down of a RS last week and the expectation/plan that pps will rise to and remain over $1 by 3 months to maintain NASDAQ listing criteria would have driven it up. Maybe all this info hasn't diffused into the market yet? Not sure.
OXGN
OXGN interesting.DATA anytime,very solid balance sheet,trading way under Net assets and The FDA already granted a Fast Track status to CA4P is a significant acknowledgement of the potential for CA4P to provide a new and better treatment option for women with platinum-resistant ovarian cancer.
OXGN to hit two birds with one stone,awesome: https://biz.yahoo.com/e/160602/oxgn8-k.html
Actually 4 pluses:this https://clinicaltrials.gov/ct2/show/NCT02132468
and this: Assets/debt ratio=12 very solid(even rare),Net Assets(total assets minus total liabilities)= $22m. currently trading under $17m cap.
my biggest gainer today, some one has been very patient with it today. It'll either fall to pieces before close or have something in the pipe for next week
yep, moves really nice on it too !
Only thing that will make this run is news!!$$$$glta
This thing is stuck on .72 ...very frustrating..glta..hopefully we move north today!!$$$$$
I'll just hang in till some more news, probably get more if it hits 50's again
Low vol shake. Something fishy going on here. Might pop unexpectedly
I wouldn't either
I cant think of a higher risk play then shorting a biotech with relatively low float
What's up with pm?? Hoping for a nice bounce today $$$$ glta
Wow, the shorts really built a position in this thing yesterday they better hope there right, this thing could be one big short squeeze ??????????
Agree. Hoping to get more before it really starts moving. Results of this trial were a big deal, so just a matter of time until it really pops. I was surprised it didn't move higher yesterday.
OXGN
The last 2 hours of trading, someone was loading a ton of shares. Up trend should still continue today.
Hope so, but why do you think that? From the rebound end of day, or do you expect another catalyst?
OXGN
* * $OXGN Video Chart 05-24-16 * *
Link to Video - click here to watch the technical chart video
Me too..going to be good $$$$$
OXGN is going to be a beast in the morning. Excited to see what tomorrow brings.
Should see a power hour push!
same the float is getting eat up, around 24 mil
Just looking at the level 2 this thing is going to run into the close. I am showing it is extremely thin to $1.40
Level 2 is so thin on this all the way up! This is going to be a multi day runner and most likeley a nice gap up in the AM.
Agree...gltua $$$$
I think we see higher by EOD. Guessing it will close in on (or just above) that $1 again.
Background Fred Driscoll. He brings a lot of experience to the table.
http://www.bloomberg.com/research/stocks/people/person.asp?personId=548473&privcapId=61177529
I'm feeling the same actually. A nice rise from here would prove strength to me.
>=90% chance OXGN raises money in next 48 hours, IMO.
I broke even on this one.
eod will tell :)
Followers
|
86
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1175
|
Created
|
07/29/03
|
Type
|
Free
|
Moderators |
http://www.oxigene.com/about/companyinfo.asp
http://finance.yahoo.com/q/h?s=OXGN
OXiGENE, Inc., a biopharmaceutical company, engages in the development of novel small-molecule therapeutics to treat cancer and eye diseases. The company focuses on the development and commercialization of drug candidates that disrupt abnormal blood vessels associated with solid tumor progression and visual impairment. It develops vascular disrupting agents (VDAs) and ortho-quinone prodrugs (OQPs). It develops VDAs for indications in oncology and ophthalmology; and OQPs for indications in oncology. The company?s products are in various clinical and preclinical trials for oncology and ophthalmology, as a single-agent and in combination with other therapies, including chemotherapy, radiotherapy, antibody therapy, and anti-vascular endothelial growth factor therapy. The company has collaborations with a various university and research institutions, including Gray Cancer Institute, Middlesex, the United Kingdom; Baylor University, Waco, Texas; Arizona State University, Tempe, Arizona; The University of Texas MD Anderson Cancer Center, Houston, Texas; and Beth Israel Deaconess Medical Center, Boston, Massachusetts. The company was incorporated in 1988 and is headquartered in Waltham, Massachusetts.
>
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |